av/marksans-pharma--big.svg

NSE:MARKSANS

Marksans Pharma

  • Stock

223.75

+1.99%

4.36

INR last updated 05/08 01:57:14

Last Close

219.39

02/05 08:51

Market Cap

87.17B

Beta: 1.23

Volume Today

1.51M

Avg: 2.09M

PE Ratio

22.85

PFCF: -

Dividend Yield

0.33%

Payout:0%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascu...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    0.511.522020-09-302021-09-302022-09-302024-02-132024-11-06

    Revenue (Estimate*)

    1B2B3B4B5B6B2020-09-302021-09-302022-09-302024-02-132024-11-06

    *Estimate based on analyst consensus